News
Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...
Even before the FDA's authorization of Moderna and J&J boosters, CDC data show that more than 1.6 million people have received a Moderna booster and more than 11,000 another shot of J&J's ...
As a scientist with the FDA explained, a Moderna study of about 170 people who received a booster shot missed its goal of increasing immune activity fourfold against COVID-19.
The FDA advisory panel also will consider mixing and matching vaccines. An independent Food and Drug Administration advisory panel on Thursday voted unanimously to authorize Moderna Covid-19 ...
The FDA’s panel of pediatric and immunology experts reviewed two studies conducted by Moderna in children, which showed that kids ages six to 17 generated levels of virus-neutralizing antibodies ...
The Food and Drug Administration's vaccine advisory committee met Thursday to consider whether a Moderna booster shot is safe and helpful in the country's fight against COVID-19. Today, the FDA's ...
The FDA’s vaccine advisers will evaluate next week Moderna’s Covid-19 vaccines for children 6 months through 5 years and 6 years through 17 years should be granted emergency use authorization.
FDA scientists and experts said there was strong evidence the Moderna vaccine is 94.5% effective at preventing COVID-19 cases at least 14 days after vaccination and that there were no significant ...
FDA review finds Moderna’s booster dose of its coronavirus vaccine strengthens disease-fighting response Updated October 12, 2021 More than 3 years ago Summary ...
The FDA didn’t find any significant safety issues with the Moderna vaccine, aside from common side effects such as fatigue and muscle aches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results